Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion-Reference-Cited by-同舟云学术

Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion

Published:2019-01-09 Issue:474 Volume:11 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Guo Mengfei¹^ORCID,Wu Feng¹^ORCID,Hu Guorong¹^ORCID,Chen Lian¹^ORCID,Xu Juanjuan¹,Xu Pingwei²,Wang Xuan¹,Li Yumei¹,Liu Shuqing¹^ORCID,Zhang Shuai¹^ORCID,Huang Qi¹^ORCID,Fan Jinshuo¹,Lv Zhilei¹,Zhou Mei¹^ORCID,Duan Limin¹,Liao Tingting¹,Yang Guanghai³,Tang Ke²,Liu Bifeng⁴,Liao Xiaofei⁵,Tao Xiaonan¹,Jin Yang¹^ORCID

Affiliation:

1. Key Laboratory of Pulmonary Diseases of Health Ministry, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

2. Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

3. Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

4. Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

5. School of Computer Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.

Abstract

This study investigated the application of a therapeutic tumor cell–derived microparticle-based nanodelivery platform in malignant pleural effusion.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hubei Province

Health and Planning Commission Fund of Hubei Province

Science and Technology Support Program of Hubei Province

Soundny (Sheng-Qi-An) Biotech

Wuhan Planning Project of Science and Technology

the Special Fund for Technological Innovation of Hubei

State Project for Essential Drug Research and Development